Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hormone Therapy Failure in Human Prostate Cancer: Analysis by Complementary DNA and Tissue Microarrays

20 Oct 1999

Abstract excerpt

BACKGROUND: The molecular mechanisms underlying the progression of prostate cancer during hormonal therapy have remained poorly understood. In this study, we developed a new strategy for the identification of differentially expressed genes in hormone-refractory human prostate cancer by use of a combination of complementary DNA (cDNA) and tissue microarray technologies. METHODS: Differences in gene expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Biosensing Techniques and Applications
Share to Heat shock proteins research
Share to Prostate Cancer Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10528027
DOI: 10.1093/jnci/91.20.1758

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hormone Therapy Failure in Human Prostate Cancer: Analysis by Complementary DNA and Tissue MicroarraysPMID 10528027Read ↗

Microarray analysis of prostate cancer progression to reduced androgen dependence: Studies in unique models contrasts early and late molecular eventsSemantic proximity Read ↗

Identification of differentially expressed genes associated with androgen‐independent growth of prostate cancerSemantic proximity Read ↗

Molecular Features of Hormone-Refractory Prostate Cancer Cells by Genome-Wide Gene Expression ProfilesSemantic proximity Read ↗

Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signalingSemantic proximity Read ↗

Androgen-regulated and highly tumorigenic human prostate cancer cell line established from a transplantable primary CWR22 tumor.Semantic proximity Read ↗

A new human prostate carcinoma cell line, 22Rv1.Semantic proximity Read ↗

Context-Dependent Hormone-Refractory Progression Revealed through Characterization of a Novel Murine Prostate Cancer Cell LineSemantic proximity Read ↗

Metastatic phenotype in CWR22 prostate cancer xenograft following castration.Semantic proximity Read ↗

Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).Semantic proximity Read ↗

Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer.Semantic proximity Read ↗

NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer GrowthSemantic proximity Read ↗

EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.